Kentucky Statutes 216B.206 – Eligibility to register as nonsurgical abortion provider — Requirements for registered physicians
Current as of: 2024 | Check for updates
|
Other versions
(1) To be eligible to register as a nonsurgical abortion provider, the cabinet shall require a qualified physician to:
(a) Be licensed to practice medicine and in good standing in Kentucky;
(b) Examine any patient in-person prior to providing abortion-inducing drugs; (c) Sign an annual “Dispensing Agreement Form,” to be developed and
provided by the cabinet, prior to providing abortion-inducing drugs;
(d) Inform the patient of gestational age-specific risks of using abortion-inducing drugs;
(e) Assess for signs of domestic abuse, reproductive control, human trafficking, and other signals of coerced abortion, per current state guidelines;
(f) Inform the patient that studies show babies born following the abortion reversal process have a rate of birth defects no higher than the general population;
(g) Inform the patient that studies show that following a reversal process or otherwise treating a pregnant patient with progesterone during pregnancy does not lead to increased mortality rates;
(h) Refrain from intentionally or knowingly supplying abortion-inducing drugs to patients who present with any of the following:
1. Absence of a pregnancy;
2. Being post-seventy (70) days gestation or post-ten (10) weeks of pregnancy; or
3. Risk factors associated with abortion-inducing drugs, including but not limited to:
a. A history of ectopic pregnancies;
b. Problems with the adrenal glands near the kidneys;
c. Being treated with long-term corticosteroid therapy;
d. Allergic reactions to abortion-inducing drugs, mifepristone, misoprostol, or similar drugs;
e. Bleeding problems or taking anticoagulant drug products;
f. Inherited porphyria;
g. An intrauterine device in place; or
h. Being Rh negative, requiring treatment with the prevailing medical standard of care to prevent harmful fetal or child outcomes or Rh incompatibility in future pregnancies before providing abortion-inducing drugs;
(i) Provide or refer for emergency surgical intervention in cases of incomplete abortion, severe bleeding, or other abortion complications or adverse events, through maintaining hospital admitting privileges or entering into a written agreement with an associated physician;
(j) Ensure patient access to medical facilities equipped to provide blood
transfusions and resuscitation or other necessary treatments, if necessary;
(k) Sign, and ensure that the patient signs, all legally required informed- consent material, provide the patient with a copy showing both signatures, and place the original in the patient’s medical record and forward to a certified pharmacy, if appropriate;
(l) Record the serial number, National Drug Code, lot number, and expiration date from each package of each abortion-inducing drug given to the patient in the patient’s medical record;
(m) Submit a written protocol of how efforts will be made to schedule a follow-up appointment with the patient within fourteen (14) days to ensure a completed abortion;
(n) Submit a written protocol of how complications or adverse events will be handled by the registered physician and submit a copy of a signed contract with an associated physician credentialed to handle certain complications if necessary;
(o) Abide by all applicable state and federal laws regarding medical records retention, confidentiality, and privacy; and
(p) Agree to follow and document compliance with all other legally required conditions for performing an abortion in Kentucky.
(2) The cabinet shall require the following of registered physicians:
(a) Maintain hospital admitting privileges at one (1) or more hospitals in the county or contiguous county where abortion-inducing drugs will be provided and inform the patient of the hospital or hospitals where the physician holds admitting privileges; or
(b) Enter into a written associated physician agreement as required in KRS
311.7734, with a physician in the county or contiguous county where abortion-inducing drugs will be provided. The written agreement shall meet these conditions:
1. A physician who will be providing an abortion-inducing drug shall notify the patient of the location of the hospital at which the associated physician has admitting privileges;
2. The physician shall keep, at the location of his or her practice, a copy of the written agreement;
3. The cabinet shall annually submit a copy of the written agreement to each hospital located in the county or a county that is contiguous to the county where abortion-inducing drugs will be provided;
4. The agreement shall be renewed annually; and
5. The agreement shall include a requirement that the physician provide to the patient, and require the patient to sign, all legally required informed-consent material.
Effective:April 14, 2022
History: Created 2022 Ky. Acts ch. 210, sec. 17, effective April 14, 2022.
(a) Be licensed to practice medicine and in good standing in Kentucky;
Terms Used In Kentucky Statutes 216B.206
- Contract: A legal written agreement that becomes binding when signed.
- Domestic: when applied to a corporation, partnership, business trust, or limited liability company, means all those incorporated or formed by authority of this state. See Kentucky Statutes 446.010
- Federal: refers to the United States. See Kentucky Statutes 446.010
- State: when applied to a part of the United States, includes territories, outlying possessions, and the District of Columbia. See Kentucky Statutes 446.010
- Treatment: when used in a criminal justice context, means targeted interventions
that focus on criminal risk factors in order to reduce the likelihood of criminal behavior. See Kentucky Statutes 446.010
(b) Examine any patient in-person prior to providing abortion-inducing drugs; (c) Sign an annual “Dispensing Agreement Form,” to be developed and
provided by the cabinet, prior to providing abortion-inducing drugs;
(d) Inform the patient of gestational age-specific risks of using abortion-inducing drugs;
(e) Assess for signs of domestic abuse, reproductive control, human trafficking, and other signals of coerced abortion, per current state guidelines;
(f) Inform the patient that studies show babies born following the abortion reversal process have a rate of birth defects no higher than the general population;
(g) Inform the patient that studies show that following a reversal process or otherwise treating a pregnant patient with progesterone during pregnancy does not lead to increased mortality rates;
(h) Refrain from intentionally or knowingly supplying abortion-inducing drugs to patients who present with any of the following:
1. Absence of a pregnancy;
2. Being post-seventy (70) days gestation or post-ten (10) weeks of pregnancy; or
3. Risk factors associated with abortion-inducing drugs, including but not limited to:
a. A history of ectopic pregnancies;
b. Problems with the adrenal glands near the kidneys;
c. Being treated with long-term corticosteroid therapy;
d. Allergic reactions to abortion-inducing drugs, mifepristone, misoprostol, or similar drugs;
e. Bleeding problems or taking anticoagulant drug products;
f. Inherited porphyria;
g. An intrauterine device in place; or
h. Being Rh negative, requiring treatment with the prevailing medical standard of care to prevent harmful fetal or child outcomes or Rh incompatibility in future pregnancies before providing abortion-inducing drugs;
(i) Provide or refer for emergency surgical intervention in cases of incomplete abortion, severe bleeding, or other abortion complications or adverse events, through maintaining hospital admitting privileges or entering into a written agreement with an associated physician;
(j) Ensure patient access to medical facilities equipped to provide blood
transfusions and resuscitation or other necessary treatments, if necessary;
(k) Sign, and ensure that the patient signs, all legally required informed- consent material, provide the patient with a copy showing both signatures, and place the original in the patient’s medical record and forward to a certified pharmacy, if appropriate;
(l) Record the serial number, National Drug Code, lot number, and expiration date from each package of each abortion-inducing drug given to the patient in the patient’s medical record;
(m) Submit a written protocol of how efforts will be made to schedule a follow-up appointment with the patient within fourteen (14) days to ensure a completed abortion;
(n) Submit a written protocol of how complications or adverse events will be handled by the registered physician and submit a copy of a signed contract with an associated physician credentialed to handle certain complications if necessary;
(o) Abide by all applicable state and federal laws regarding medical records retention, confidentiality, and privacy; and
(p) Agree to follow and document compliance with all other legally required conditions for performing an abortion in Kentucky.
(2) The cabinet shall require the following of registered physicians:
(a) Maintain hospital admitting privileges at one (1) or more hospitals in the county or contiguous county where abortion-inducing drugs will be provided and inform the patient of the hospital or hospitals where the physician holds admitting privileges; or
(b) Enter into a written associated physician agreement as required in KRS
311.7734, with a physician in the county or contiguous county where abortion-inducing drugs will be provided. The written agreement shall meet these conditions:
1. A physician who will be providing an abortion-inducing drug shall notify the patient of the location of the hospital at which the associated physician has admitting privileges;
2. The physician shall keep, at the location of his or her practice, a copy of the written agreement;
3. The cabinet shall annually submit a copy of the written agreement to each hospital located in the county or a county that is contiguous to the county where abortion-inducing drugs will be provided;
4. The agreement shall be renewed annually; and
5. The agreement shall include a requirement that the physician provide to the patient, and require the patient to sign, all legally required informed-consent material.
Effective:April 14, 2022
History: Created 2022 Ky. Acts ch. 210, sec. 17, effective April 14, 2022.